Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
|
|
19.
|
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. [electronic resource] by
- Fava, M
- Johe, K
- Ereshefsky, L
- Gertsik, L G
- English, B A
- Bilello, J A
- Thurmond, L M
- Johnstone, J
- Dickerson, B C
- Makris, N
- Hoeppner, B B
- Flynn, M
- Mischoulon, D
- Kinrys, G
- Freeman, M P
Publication details: Molecular psychiatry 10 2016
In:
Molecular psychiatry vol. 21
Availability: No items available.
|
|
20.
|
A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. [electronic resource] by
- Fava, M
- Johe, K
- Ereshefsky, L
- Gertsik, L G
- English, B A
- Bilello, J A
- Thurmond, L M
- Johnstone, J
- Dickerson, B C
- Makris, N
- Hoeppner, B B
- Flynn, M
- Mischoulon, D
- Kinrys, G
- Freeman, M P
Producer: 20170905
In:
Molecular psychiatry vol. 21
Availability: No items available.
|